טוען...
Prolonged intralymphatic delivery of dendritic cells through implantable lymphatic ports in patients with advanced cancer
BACKGROUND: The currently-used modes of administration of immunotherapeutic agents result in their limited delivery to the lymph nodes and/or require repetitive ultrasound-guided nodal injections or microsurgical lymphatic injections, limiting their feasibility. Here, we report on the feasibility an...
שמור ב:
| הוצא לאור ב: | J Immunother Cancer |
|---|---|
| Main Authors: | , , , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
BioMed Central
2016
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4835859/ https://ncbi.nlm.nih.gov/pubmed/27096100 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40425-016-0128-y |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|